Santen launches Ducressa for post-cataract surgery
August 16, 2022Manufacturing and Production
Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery Santen has announced the launch of Ducressa …
The impact of COVID-19 on the fight against AMR
August 16, 2022Manufacturing and Production
How the responses to the COVID-19 pandemic have affected antibiotic-resistant bacteria Responses to the COVID-19 pandemic may have impacted …
BrainStorm’s ALS-combatting drug finally on its way to the FDA
August 16, 2022Manufacturing and Production
BrainStorm Cell Therapeutics’ NurOne was rejected by the Food and Drug Association in February 2021 but this year, after consulting …
UK first country to approve bivalent booster which targets both original COVID-19 as well as the Omicron strain
August 16, 2022Manufacturing and Production
The UK medicines regulator (MHRA) has given the Moderna-made vaccine conditional approval, backed up by the Joint Committee on Vaccination …
Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
August 15, 2022Sales and Marketing
The European study will evaluate the use of the human recombinant monoclonal antibody nirsevimab Sanofi and the National Institute …
NHS England outlines measures to boost capacity ahead of substantial winter pressures
August 15, 2022Sales and Marketing
The package of measures includes creating the equivalent of 7,000 additional hospital beds NHS England has announced a package …
Focused ultrasound therapies could be made more affordable by 3D-printed acoustic holograms to help overcome the blood-brain barrier
August 15, 2022Sales and Marketing
The 3D-printed acoustic hologram is used with focused ultrasound (FUS) to create a more controlled and precise opening in the …
Cognitive rehabilitation therapy may help older adults clear COVID-19-related brain fog
August 15, 2022Sales and Marketing
Medical centres in the US have started referring older patients with long COVID-19-related symptoms for cognitive rehabilitation in order to …
MHRA grants marketing authorisation for Novartis’ Pluvicto
August 12, 2022Medical Communications
Radioligand therapy is used to treat patients with advanced prostate cancer
Bristol Myers Squibb and GentiBio in $1.9bn deal to develop inflammatory bowel disease therapies
August 12, 2022Medical Communications
BMS will have the right to develop and advance up to three of the resulting programmes into clinical trials
Blood tests taken within 24 hours of a traumatic brain injury can predict whether a patient will die, or survive with serious disability
August 12, 2022Medical Communications
The tests’ results are available within minutes and will be useful in helping trauma ward staff and surgeons to decide …
ONS figures show rapid decrease in people with higher COVID-19 antibody figures
August 12, 2022Medical Communications
The amount of UK residents with higher levels of COVID-19 antibodies is falling, ONS statistics show.
Pfizer to buy Global Blood Therapeutics for $5.4bn
August 11, 2022Business Services
Pfizer Inc is to pay $5.4 billion in cash to acquire sickle cell disease drug-maker Global Blood Therapeutics, according to …
All children aged one to nine in London to be offered polio vaccine
August 11, 2022Business Services
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that a targeted inactivated polio vaccine (IPV) booster be given …
NHS backlog of 22,500 longest-wait patients slashed to fewer than 200, says NHS England figures
August 11, 2022Business Services
The COVID-19 pandemic caused a huge backlog in patients as medical services focused their efforts on combating the virus. At …
COVID-19 sewage surveillance labs join the hunt for monkeypox
August 11, 2022Business Services
Wastewater surveillance techniques are being adapted for use in monitoring the spread of monkeypox across the San Francisco Bay Area …
Study highlights major factors in shaping cross-disorder cortical abnormalities
August 10, 2022Research and Development
The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …
Survey reveals 45% of junior doctors are considering leaving the profession
August 10, 2022Research and Development
1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …
Karuna Therapeutics announces positive results from Phase III trial into schizophrenia
August 10, 2022Research and Development
Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …
Tagrisso combined with Hutchmed drug clears lung cancer test
August 10, 2022Research and Development
Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …
Latest content
FibroFind appoints Lee Borthwick as CEO
